Kunio Sugahara

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 146(Granted Patents)

Location History:

Iruma, JP (2001)
Tokyo, JP (2012)
Osaka, JP (2011 - 2015)

Company Filing History:

6 out of 257

Mitsubishi Tanabe Pharma Corporation

Years Active: 2001-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9125915 - Antitumor agent (2015-09-08),

2. 8809304 - Amine compound and use thereof for medical purposes (2014-08-19),

3. 8476260 - Antitumor agent (2013-07-02),

4. 8129361 - Amine compound and pharmaceutical use thereof (2012-03-06),

5. 8114902 - 2-aminobutanol compound and use thereof for medical purposes (2012-02-14),

6. 8044042 - Thienotriazolodiazepine compound and medicinal use thereof (2011-10-25),

7. 6288061 - Imidazole derivatives (2001-09-11),

Title: Inventor Kunio Sugahara

Introduction: Kunio Sugahara is a renowned inventor based in Osaka, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Kunio Sugahara holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Kunio Sugahara has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Kunio Sugahara has collaborated with top companies, such as tech giants and automotive manufacturers, to bring his inventions to the market, solidifying his reputation as a visionary inventor.

Conclusion: Kunio Sugahara's passion for innovation and his relentless drive to push the boundaries of technology have established him as a prominent figure in the world of inventions, inspiring the next generation of inventors to think boldly and create fearlessly.

This text is generated by artificial intelligence and may not be accurate.